Lenvatinib in Metastatic DTC (Differentiated Thyroid Cancer)- A Pragmatic Approach with Dosing

Arif Shaukat and J Ansari
Additional contact information
J Ansari: Prince Sultan Military Medical City Riyadh

Biomedical Journal of Scientific & Technical Research, 2017, vol. 1, issue 1, 219-221

Abstract: Thyroid cancer has become one of the fastest-increasing cancers in recent years. There are nearly 300,000 new cases of thyroid cancer annually and approximately 40,000 people die from thyroid cancer worldwide each year [1]...

Keywords: Biomedical Sciences; Biomedical Research; Technical research; Differentiated thyroid cancer (DTC); Lenvatinib; Multi kinase inhibitors; Metastatic; Radio iodine refractory (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.000156.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.000156.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:1:y:2017:i:1:p:219-221

DOI: 10.26717/BJSTR.2017.01.000156

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().